Institute of Pathology

An Investigation of Mechanisms of Response and Resistance to Enfortumab Vedotin in Urothelial Cancer (PH-NIH_Enformtumab Vedotin) June 1, 2024 - May 31, 2027 J113: Impact of the secretome of ATF2-deficient colon cancer cells on mesothelial cells during peritoneal metastasis Nov. 1, 2024 - April 30, 2027 D041: Ferroptosis and phospholipid metabolism for chemo- and immunotherapy sensitization in urothelial cancer July 1, 2023 - June 30, 2026 P150: Establishing a consensus protocol for detection of disseminated cancer cells in NSCLC patients Aug. 15, 2024 - Feb. 14, 2026 J101: AI-based support for histopathology evaluation of autoinflammatory and malignant GI diseases Jan. 1, 2023 - Dec. 31, 2025 J102: The role of cDC1s in abscopal effects of a multimodal radioimmunotherapy including whole tumor cell vaccines Dec. 1, 2022 - Nov. 30, 2025 P126: Mesenteries as a novel ex vivo co-culture model to study peritoneal metastasis May 1, 2023 - Sept. 1, 2024 Erstellung eines öffentlich zugänglichen, multimodalen Datensatzes für Kopf- und Halstumore (HANCOCK A) Nov. 1, 2022 - April 30, 2024 Translational spatial tumor immunobiology of urothelial cancer March 1, 2023 - Feb. 29, 2024 VerDiGes - PADEL /Begleitung und Studiendesign zur PD-L1-Classifierentwicklung (PH-BMWi_VerDiGes PADEL) March 15, 2021 - March 14, 2023